Skip to main content
Caplight Logo









Novoma

Novoma

Private
ToulouseConsumer & Commercehttps://novoma.com/en

Last Round

M&A

Apr 7, 2025

Company Overview

Novoma is a health and wellness company that develops and sells a range of natural food supplements, including vitamins, minerals, and plant-based products, designed to support daily well-being.

Sector

Consumer & Commerce

Verticals

D2C Brands, E-commerce, Sports & Fitness, Fashion & Beauty

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

dietary supplementsDTCdirect-to-consumerwellness brandvitamin supplementsnutraceuticalssubscription commercemarine collagenmagnesium bisglycinateadaptogensashwagandhae-commercehealth supplementsspirulinabeauty supplements

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novoma Comparables

Compare Novoma with similar companies based on industry and business-model similarity.

Novoma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nutri&Co
94%
Nutripure
86%
Dynveo
86%

Novoma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AApr 7, 2025

Key People

Founding team and executive leadership

Alexandre Garnier

Co-founder and CEO

Founding Team

Novoma Investors

Notable investors and investment history

Novoma investors
InvestorRounds
Kresk DéveloppementM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2025

    Funding round led by Kresk Développement, a family office.

  • Oct 29, 2024

    Monthly visitors increased 40% MoM.

Novoma Filings

Explore SEC and related filing metadata, where available.

Novoma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novoma's valuation, stock price, and market status.

Is Novoma a public or private company?

Novoma is a private company.

What is the current stock price of Novoma?

Novoma is a private company with no public stock price. No recent secondary market data is available.

How much is Novoma worth (valuation)?

Valuation information for Novoma is not publicly available.

Can I buy Novoma stock?

Novoma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novoma's last funding round?

Novoma's most recent funding round was M&A on April 7, 2025.

Who are the main investors in Novoma?

Key investors in Novoma include Kresk Développement.

Will Novoma IPO soon?

No public IPO plans have been announced for Novoma.

How can I track Novoma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novoma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToulouse
Employee Range35
Year Founded2012
Last FundingApr 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?